Table 1.

Anamnestic, histological, and microbiologic preoperative data.

Patient#	Gender	Age (m)	Weight (kg, percentile)	Type of DCM	Histology	Aspecific symptoms prior admission	Viral test
1	M	8.6	8.0, 10th percentile	LV non-compaction cardiomyopathy [heterozygous mutation of TPM1 gene° (de novo) and of ABCC9 gene (parental)]	Not performed	Yes	Not performed
2	M	42.2	12.0, 3rd percentile	Fulminant myocarditis in idiopathic unrecognized DCM	Active lymphocytic myocarditis with endocardial fibroelastosis	Yes	Negative
3	M	3.9	5.9, 10th−25th percentile	Acute myocarditis	Active lymphocytic myocarditis with endocardial fibroelastosis	No	CMV-DNA positive on blood and urine samples, negative in myocardial biopsy
4	F	12.5	7.7, <3rd percentile	PVB19 chronic myocarditis	Chronic myocarditis in activity Phase	Yes	PVB19 on blood sample and myocardial biopsy
5	M	5.7	4.8, <3rd percentile	Acute myocarditis	Active lymphocytic myocarditis	No	HHV6-DNA positive on blood sample, genomic integration in patient's cells, negative in myocardial biopsy

CMV, cytomegalovirus; DCM, dilated cardiomyopathy; PVB19, parvovirus B19; LV, left ventricular.

°associated with non-compaction cardiomyopathy.